Monashee Investment Management »

Karyopharm Therapeutics shares owned by Monashee Investment Management

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Monashee Investment Management from 13F filings

Historical chart of Monashee Investment Management investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Monashee Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Monashee Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $26k 132k 0.19
2023-12-31 $35k 132k 0.26
2022-12-31 $1.6M 482k 3.40

More positions owned by Monashee Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Index Fds Total Stk Mkt (VTI)
Arthur J. Gallagher & Co. (AJG)
Landbridge Company Cl A (LB)
Sable Offshore Corp Com Shs (SOC)
Boeing Company (BA)
Amer Sports Com Shs (AS)
Abacus Life Cl A (ABL)
Biodesix (BDSX)

View all positions for Monashee Investment Management

Top funds holding Karyopharm Therapeutics

Vanguard Group
Adage Capital Partners GP
Palo Alto Investors
BlackRock
Morgan Stanley
Citadel Advisors
Marshall Wace
Eversept Partners
Avidity Partners Management
UBS O'Connor
GSA Capital Partners
CAM Group Holding A/S
Geode Capital Management
Goldman Sachs Group
Bnp Paribas Arbitrage, Snc

View all funds holding Karyopharm Therapeutics